Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable...
Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)
About this item
Full title
Author / Creator
the RESPOND investigators , RESPOND investigators , Shorr, Andrew F , Janes, Jonathan M , Artigas, Antonio , Tenhunen, Jyrki , Wyncoll, Duncan LA , Mercier, Emmanuelle , Francois, Bruno , Vincent, Jean-Louis , Vangerow, Burkhard , Heiselman, Darell , Leishman, Amy G , Zhu, Yajun E and Reinhart, Konrad
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Serial alterations in protein C levels appear to correlate with disease severity in patients with severe sepsis, and it may be possible to tailor severe sepsis therapy with the use of this biomarker. The purpose of this study was to evaluate the dose and duration of drotrecogin alfa (activated) treatment using serial measurements of protein C compa...
Alternative Titles
Full title
Randomized trial evaluating serial protein C levels in severe sepsis patients treated with variable doses of drotrecogin alfa (activated)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3219981
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3219981
Other Identifiers
ISSN
1364-8535,1466-609X
E-ISSN
1364-8535,1466-609X
DOI
10.1186/cc9382
